Absci Corporation ABSI
$6.92
▲ +4.45% 24H
About
Absci Corporation is a clinical-stage biopharmaceutical company that specializes in using generative artificial intelligence to design and create biologic drugs. The company operates a data-first drug creation platform that integrates AI models with scalable wet lab technologies to discover, optimize, and produce thera…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees140
TickerABSI
Statistics
Market Cap$1.08B
Revenue (TTM)$2.8M
Net Income-$115.2M
Net Margin-4113.7%
EPS$-0.84
P/E-8.10
P/S552.80
P/B5.88
EV/EBITDA-7.67
ROE-63.9%
Dividend Yield—
Price$6.92
Data: Twelve Data · Revenue = mcap / P/S